Menu Close

Virtual care company Recuro Health raises $47 million

Virtual integrated care platform Recuro Health announced it closed a $47 million Series B financing round. 

ARCH Venture Partners, the Flippen Group, GPG Ventures, 4D Capital and other investors participated in the raise.


Recuro Health’s Digital Medical Home offering allows patients to virtually access healthcare services, including behavioral healthcare, virtual primary and urgent care, genomics testing and at-home lab testing. 

The company also works with employers to create customizable digital health offerings for their employees, and with health plans and providers to help connect their members and patients to the right care teams. 

Recuro will use the funds to progress and scale its Digital Medical Home care model, which includes virtual primary care and behavioral health offerings.  

“The continued support of our investors is a clear sign of their confidence in our mission,” Michael Gorton, CEO and founder of Recuro Health, said in a statement. “We have an extraordinary team at Recuro dedicated to evolving healthcare to be more proactive and personal, resulting in improved outcomes, better patient engagement and lower costs. In this next phase of our company growth and expansion, we are committed to building upon the success of our Digital Medical Home and continuing to advance the next generation of digital care services.”


In 2021, the company garnered $15 million in Series A funding

That same year, the company purchased MyLifeIQ, an epigenetics platform, and SupDoc, an AI-enabled virtual health platform.

Last year, Recuro acquired WellVia, a virtual health provider that connects patients with physicians and behavioral health specialists. 

It also announced its acquisition of digital health company Competitive Health, which offers employers products to help reduce costs, maximize employer ROI and promote engagement. 

Recuro Health recently announced it would join Microsoft as a featured partner at HIMSS23 Global Conference next week. 

Glen Tullman will offer more detail in the HIMSS23 session “Views from the Top: Existential Crisis or Inflection Point Opportunity? An Industry Maverick’s Perspective.” It is scheduled for Tuesday, April 18, at 3 p.m. – 4 p.m. CT at the South Building, Level 1, room S100 B.

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *